Therapeutic Asset Ratings
396 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
ly4052031
Cervical Cancer
Eli Lilly and Company
P1
C
(37)
ly4052031
Esophageal Cancer
Eli Lilly and Company
P1
C
(37)
ly4052031
Head And Neck Squamous Cell Carcinoma
Eli Lilly and Company
P1
C
(37)
ly4052031
Metastatic Solid Tumor
Eli Lilly and Company
P1
C
(37)
ly4052031
Triple-Negative Breast Carcinoma
Eli Lilly and Company
P1
C
(37)
ly4066434.
Metastatic Solid Tumor
Eli Lilly and Company
P1
C
(37)
ly4066434.
Pancreatic Ductal Adenocarcinoma
Eli Lilly and Company
P1
C
(37)
ly4086940
Obesity Disorder
Eli Lilly and Company
P1
C
(37)
ly4101174
Cervical Cancer
Eli Lilly and Company
P1
C
(37)
ly4101174
Esophageal Cancer
Eli Lilly and Company
P1
C
(37)
ly4101174
Head And Neck Squamous Cell Carcinoma
Eli Lilly and Company
P1
C
(37)
ly4101174
Metastatic Solid Tumor
Eli Lilly and Company
P1
C
(37)
ly4101174
Triple-Negative Breast Carcinoma
Eli Lilly and Company
P1
C
(37)
ly4167586
Obesity Disorder
Eli Lilly and Company
P1
C
(37)
ly4170156
Non-Small Cell Lung Carcinoma
Eli Lilly and Company
P1
C
(37)
ly4175408
Non-Small Cell Lung Carcinoma
Eli Lilly and Company
P1
C
(37)
ly4175408
Triple-Negative Breast Carcinoma
Eli Lilly and Company
P1
C
(37)
ly4257496
Breast Neoplasm
Eli Lilly and Company
P1
C
(37)
ly4337713
Breast Neoplasm
Eli Lilly and Company
P1
C
(37)
ly4584180
Follicular Lymphoma
Eli Lilly and Company
P1
C
(37)
[Ac-225]-Psma-62
Prostate Cancer
Eli Lilly and Company
P1
C
(36)
Brenipatide
Obesity Disorder
Eli Lilly and Company
P1
C
(36)
Loxo-338
Plasma Cell Myeloma
Eli Lilly and Company
P1
C
(36)
Loxo-783
Breast Cancer
Eli Lilly and Company
P1
C
(36)
ly3200882
Neoplasm
Eli Lilly and Company
P1
C
(36)
Showing 351 to 375 of 396 assets
Previous
Page 15 of 16
Next